Gilligan Sarah 4

4 · GAP INC · Filed Mar 18, 2025

Form 4

Period: 2025-03-17

Chief Sup Chn & Transform Ofcr

Transactions

Sale
Common Stock
2025-03-18$19.59/sh−804$15,747→ 3,644 total
Exercise/Conversion
Restricted Stock Unit
2025-03-18−7,403→ 80,994 total
Exercise: $0.00→ Common Stock (7,403 underlying)
Sale
Common Stock
2025-03-17$20.00/sh−1,830$36,600→ 804 total
Exercise/Conversion
Common Stock
2025-03-18+7,403→ 8,207 total
Tax Payment
Common Stock
2025-03-18$20.10/sh−3,759$75,556→ 4,448 total
Award
Restricted Stock Unit
2025-03-17+33,914→ 88,397 total
Exercise: $0.00→ Common Stock (33,914 underlying)

Footnotes (6)

[F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 5, 2024.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.86 to $20.08, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.46 to $19.88, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
[F4]Each restricted stock unit represents a contingent right to receive one share of Gap Inc. Common Stock.
[F5]On March 17, 2025, the reporting person was granted 33,914 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
[F6]On March 18, 2024, the reporting person was granted 29,615 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file